Yelena Mushiyakh, MD; Harsh Dangaria, MD; Shahbaz Qavi, MD; Noorjahan Ali, MD; John Pannone, MD; David Tompkins, MD (26 Januari 2012). "Treatment and pathogenesis of acute hyperkalemia". National Center for Biotechnology Information, U.S. National Library of Medicine. doi:10.3402/jchimp.v1i4.7372. Diakses tanggal 8 Maret 2020.
Roblin I, Urban M, Flicoteau D, Martin C, Pradeau D (2006). "Topical treatment of experimental hydrofluoric acid skin burns by 2.5% calcium gluconate". J Burn Care Res. 27 (6): 889–94. doi:10.1097/01.BCR.0000245767.54278.09. PMID17091088.
gla.ac.uk
"Hydrofluoric Acid"(PDF). University of Glasgow Safety and Environmental Protection Service. Diakses tanggal 8 Maret 2020.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
nih.gov
ncbi.nlm.nih.gov
Anne L Schafer, M.D.; Dolores M Shoback, M.D. (3 Januari 2016). "Hypocalcemia: Diagnosis and Treatment". National Center for Biotechnology Information, U.S. National Library of Medicine. Diakses tanggal 8 Maret 2020.
Yelena Mushiyakh, MD; Harsh Dangaria, MD; Shahbaz Qavi, MD; Noorjahan Ali, MD; John Pannone, MD; David Tompkins, MD (26 Januari 2012). "Treatment and pathogenesis of acute hyperkalemia". National Center for Biotechnology Information, U.S. National Library of Medicine. doi:10.3402/jchimp.v1i4.7372. Diakses tanggal 8 Maret 2020.
el Saadi MS, Hall AH, Hall PK, Riggs BS, Augenstein WL, Rumack BH (1989). "Hydrofluoric acid dermal exposure". Vet Hum Toxicol. 31 (3): 243–7. PMID2741315.
Roblin I, Urban M, Flicoteau D, Martin C, Pradeau D (2006). "Topical treatment of experimental hydrofluoric acid skin burns by 2.5% calcium gluconate". J Burn Care Res. 27 (6): 889–94. doi:10.1097/01.BCR.0000245767.54278.09. PMID17091088.
John P. Cunha, DO, FACOEP, ed. (2 April 2009). "Calcium Gluconate". RxList Inc. Diakses tanggal 8 Maret 2020.Pemeliharaan CS1: Banyak nama: editors list (link)
